A Novel Cell-Based Intracellular Protein–Protein Interaction Detection Platform (SOLIS) for Multimodality Screening-Reference-Cited by-同舟云学术

A Novel Cell-Based Intracellular Protein–Protein Interaction Detection Platform (SOLIS) for Multimodality Screening

Published:2021-04-28 Issue:5 Volume:10 Page:990-999
ISSN:2161-5063
Container-title:ACS Synthetic Biology
language:en
Short-container-title:ACS Synth. Biol.

Author:

Kashima Daiki¹,Kageoka Miho¹,Kimura Yosuke¹,Horikawa Makiko²,Miura Masashi³,Nakakido Makoto¹²,Tsumoto Kouhei¹²⁴^ORCID,Nagamune Teruyuki¹²,Kawahara Masahiro¹²³^ORCID

Affiliation:

1. Department of Chemistry and Biotechnology, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan

2. Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan

3. Laboratory of Cell Vaccine, Center for Vaccine and Adjuvant Research (CVAR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), 7-6-8 Saito-Asagi, Ibaraki-shi, Osaka 567-0085, Japan

4. Medical Proteomics Laboratory, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan

Funder

Japan Society for the Promotion of Science

University of Tokyo

Publisher

American Chemical Society (ACS)

Subject

Biochemistry, Genetics and Molecular Biology (miscellaneous),Biomedical Engineering,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acssynbio.0c00483

Reference20 articles.

1. From monoclonal antibodies to small molecules: the development of inhibitors targeting the PD-1/PD-L1 pathway